Adrienne Asher
@asheradrienne.bsky.social
360 followers
400 following
350 posts
poet, artist, #longcovid since 2020
swears a lot since the election
Posts
Media
Videos
Starter Packs
Adrienne Asher
@asheradrienne.bsky.social
· Jul 20
Utility of Glucagon-Like-Peptide-1-Receptor Agonists in Mast Cell Activation Syndrome
Introduction: Mast cell (MC) activation syndrome (MCAS) is a collection of illnesses rooted in inappropriate MC activation with little to no neoplasti…
www.sciencedirect.com
Adrienne Asher
@asheradrienne.bsky.social
· Jul 19
"Excited Every Day": Dr. Michael Peluso on LIINC, Long COVID and ME/CFS - Health Rising
Dr. Michael Peluso talks about the LIINC long COVID project, why he's excited every day about long COVID, and what he hopes the next 5 years will bring.
www.healthrising.org
Adrienne Asher
@asheradrienne.bsky.social
· May 18
Sympathetic Neural Overdrive, Vascular Dysfunction and Diminished Exercise Capacity in Long COVID-19 Patients: A Long-Term Study of Cardiovascular Sequelae | American Journal of Physiology-Regulatory,...
Background: We have recently showed that severe COVID patients have neurovascular dysfunction, cardiac morpho-functional alterations, and attenuated exercise capacity. However, whether these alteratio...
journals.physiology.org
Adrienne Asher
@asheradrienne.bsky.social
· May 18
Sympathetic Neural Overdrive, Vascular Dysfunction and Diminished Exercise Capacity in Long COVID-19 Patients: A Long-Term Study of Cardiovascular Sequelae | American Journal of Physiology-Regulatory,...
Background: We have recently showed that severe COVID patients have neurovascular dysfunction, cardiac morpho-functional alterations, and attenuated exercise capacity. However, whether these alteratio...
journals.physiology.org
Adrienne Asher
@asheradrienne.bsky.social
· May 18
Nicotinamide modulates gut microbial metabolic potential and accelerates recovery in mild-to-moderate COVID-19 - Nature Metabolism
In a prospective, double-blind, randomized, placebo-controlled trial, supplementation with a combination of conventional and gut-targeted nicotinamide was safe and effective in ameliorating COVID-19 s...
www.nature.com
Adrienne Asher
@asheradrienne.bsky.social
· May 18
Adrienne Asher
@asheradrienne.bsky.social
· May 15
Can Caffeine Help with Exercise in Fibromyalgia, ME/CFS and Long COVID? - Health Rising
A study suggests that caffeine helps fibromyalgia enjoy exercise more and exercise longer. Could the same be true for chronic fatigue syndrome (ME/CFS) and long COVID?
www.healthrising.org
Adrienne Asher
@asheradrienne.bsky.social
· May 13
Adrienne Asher
@asheradrienne.bsky.social
· May 13
Adrienne Asher
@asheradrienne.bsky.social
· May 13
Adrienne Asher
@asheradrienne.bsky.social
· May 13
Hyper-reactivity of CD8+ T cells and high expression of IL-3 correlates with occurrence and severity of Long-COVID
Following SARS-CoV-2 infection, some individuals develop Long-COVID-syndrome lasting for more than 3 months. We analyzed blood samples from patients w…
www.sciencedirect.com
Adrienne Asher
@asheradrienne.bsky.social
· May 13
Prevalence of Persistent Cardiovascular and Pulmonary Abnormalities on PET/MRI and DECT Imaging in Long COVID Patients
The objective of this study is to describe the prevalence of inflammatory cardiopulmonary findings in a prospective cohort of long coronavirus disease (LC) patients. Methods: Subjects with a history o...
jnm.snmjournals.org
Adrienne Asher
@asheradrienne.bsky.social
· May 13
Adrienne Asher
@asheradrienne.bsky.social
· May 13
Adrienne Asher
@asheradrienne.bsky.social
· May 13
Excess weight is associated with neurological and neuropsychiatric symptoms in post-COVID-19 condition: A systematic review and meta-analysis
Background/purpose Excess weight has been identified as a potential risk factor for post-COVID-19 condition (PCC). This systematic review and meta-analysis aimed to investigate whether excess weight i...
journals.plos.org
Adrienne Asher
@asheradrienne.bsky.social
· May 13
Clinical trial underway for potential Long Covid treatment - Schmidt Initiative for Long Covid
A clinical trial is underway to assess the effectiveness and safety of sipavibart, AstraZeneca’s long-acting monoclonal antibody designed to provide protection against Covid-19, as a potential treatme...
silc.org
Adrienne Asher
@asheradrienne.bsky.social
· Apr 23
Adrienne Asher
@asheradrienne.bsky.social
· Apr 23
Adrienne Asher
@asheradrienne.bsky.social
· Apr 23
Adrienne Asher
@asheradrienne.bsky.social
· Apr 23
Adrienne Asher
@asheradrienne.bsky.social
· Apr 23